search Browse Jobs
Local Study Associate Director (LSAD), Cell Therapy (m/f/d) - Field BasedAstraZeneca · 16 Locations
AstraZeneca logo

AstraZeneca

company page ↗ Visa Sponsoring Company

Local Study Associate Director (LSAD), Cell Therapy (m/f/d) - Field Based

✓ This company has sponsored visas before. The posting doesn't say so, but it's still worth applying.

🗓️ Posted 2026-09-23 16 Locations Full-time Hybrid Healthcare Medical
💰 Salary Not shared 📊 Market 6,500 GBP–10,000 GBP/mo

About the Company

In AstraZeneca's Cell Therapy division, we follow the science to explore and innovate. We are working towards treating, preventing, modifying, and even curing some of the world's most complex diseases. We have the potential to grow our pipeline and positively impact the lives of patients around the world. We are committed to making a difference and have built our business around our passion for science. Now we are fusing data and technology with the latest scientific innovations to achieve the next wave of breakthroughs. This role is part of the Oncology R&D team supporting the delivery of complex cell therapy clinical studies across sites. We are looking for a Local Study Associate Director (LSAD), Cell Therapy (m/f/d) - Field Based The Local Study Associate Director (LSAD), Cell Therapy is a key member of the country Cell Therapy Site Management & Monitoring organisation. You will lead Local Study Team(s) at country level and be accountable for delivering committed components of clinical studies according to agreed resources, budget and timelines. This field-based role combines strategic study leadership with hands-on responsibility for site management, monitoring, feasibility, recruitment and retention. You will support clinical trial sites throughout the study lifecycle through regular on-site presence and ensure compliance with AstraZeneca Procedural Documents, ICH-GCP and relevant local regulations. The position requires approximately 55% travel, primarily within G

Responsibilities

  • ● Lead Local Study Team(s) consisting of CRA(s) and CSA(s), coordinate activities and optimise team performance.
  • ● Hold overall responsibility for country study commitments and the timely delivery of data to the required quality, budget and timelines.
  • ● Provide end-to-end oversight of site identification, qualification, activation, initiation, management and close-out.
  • ● Conduct Site Qualification Visits, Site Initiation Visits, routine Monitoring Visits, for-cause visits and Close-Out Visits, as required by the study and risk-based monitoring strategy.
  • ● Maintain regular on-site presence at certified cell therapy centres and work closely with investigators, study coordinators and other site personnel.
  • ● Identify clinical and operational risks early, agree mitigation actions with relevant stakeholders and follow them through to resolution.
  • ● Lead or contribute to country and site feasibility activities and provide actionable input to study design, site selection, allocation and recruitment forecasts.
  • ● Develop country-specific and site-specific recruitment and retention strategies using feasibility findings, performance data and the local competitive landscape.
  • ● Ensure timely submission of required applications and documents to Ethics Committees/IRBs and Regulatory Authorities.
  • ● Oversee country study budgets and support financial and contractual processes with clinical trial sites.
  • ● Ensure the eTMF remains complete and inspection-ready and support audit, inspection and final archiving activities.
  • ● Keep local and global stakeholders informed of progress, milestones, risks and key delivery challenges.
  • ● Collaborate closely with international project teams, Medical Affairs, Site Partnerships and other internal functions.
  • ● Your Profile:
  • ● Bachelor's degree in life sciences, medicine or a comparable field; an advanced scientific degree is advantageous.
  • ● Approximately 5 years or more of experience in clinical research or pharmaceutical drug development.
  • ● Several years of hands-on clinical study monitoring experience, including site qualification, initiation, routine monitoring and close-out activities.
  • ● Excellent knowledge of ICH-GCP and relevant local regulatory requirements, with a strong understanding of clinical study management processes in Germany.
  • ● Practical experience in cell therapy studies, such as CAR-T, TCR-T, Treg or comparable cellular therapies, is strongly preferred.
  • ● Proven project, budget, risk and stakeholder management capability.